{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:33:25Z","timestamp":1788269605055,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Simcere Special Scientific Research Fund","award":["KY2579.03"],"award-info":[{"award-number":["KY2579.03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The aim of this study was to investigate the effect of Iguratimod (T-614) on rat knee osteoarthritis (KOA) and further to explore its underlying mechanism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, papain-induced KOA model was constructed. Hematoxylin and eosin (H&amp;E) staining was conducted to observe the pathological changes of cartilage tissue and Mankin scoring principle was used for quantitative scoring. Transmission electron microscopy (TEM) was applied to observe the ultrastructure of cartilage tissue. ELISA was used to measure the levels of matrix metalloproteinase 13 (MMP-13) and inflammatory factors (interleukin (IL)-6 and tumor necrosis factor a (TNF-a)) in serum. RT-qPCR and immunohistochemistry were conducted to detect mRNA expression and protein expression of key genes in Wnt\/\u03b2-catenin pathway.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>H&amp;E, Mankin scoring, and TEM data confirmed that compared with model group, T-614 significantly improved the degeneration of articular cartilage. Besides, we observed that low, middle, and high doses of T-614 could decrease the levels of MMP13, TNF-\u03b1, and IL-6 in serum to different degrees. Mechanically, T-614 downregulated the mRNA and protein expression of \u03b2-catenin and MMP13 in cartilage tissue via a dose-dependent manner, and on the contrary upregulated the mRNA and protein expression of glucogen synthase kinase-3 beta (GSK-3\u03b2).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our results suggested that T-614 can reduce the level of its downstream target gene MMP-13 and downregulate the expression of inflammatory cytokines TNF-\u03b1 and IL-6 by regulating the Wnt\/\u03b2-catenin signaling pathway, thereby inhibiting joint inflammation and controlling KOA degeneration of articular cartilage.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13018-021-02530-2","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T14:03:18Z","timestamp":1624370598000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["T-614 attenuates knee osteoarthritis via regulating Wnt\/\u03b2-catenin signaling pathway"],"prefix":"10.1186","volume":"16","author":[{"given":"Shan","family":"Cong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingrui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ta bu","family":"shi\u00b7Nu er xia ti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"issue":"28","key":"2530_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016301","volume":"98","author":"J Li","year":"2019","unstructured":"Li J, Li YX, Luo LJ, Ye J, Zhong DL, Xiao QW, et al. The effectiveness and safety of acupuncture for knee osteoarthritis: an overview of systematic reviews. Medicine (Baltimore). 2019;98(28):e16301. https:\/\/doi.org\/10.1097\/MD.0000000000016301.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"2530_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/0036933015619588","volume":"61","author":"SM Hussain","year":"2016","unstructured":"Hussain SM, Neilly DW, Baliga S, Patil S, Meek R. Knee osteoarthritis: a review of management options. Scott Med J. 2016;61(1):7\u201316. https:\/\/doi.org\/10.1177\/0036933015619588.","journal-title":"Scott Med J"},{"issue":"1","key":"2530_CR3","doi-asserted-by":"publisher","first-page":"34497","DOI":"10.1038\/srep34497","volume":"6","author":"J Cheng","year":"2016","unstructured":"Cheng J, Hu X, Dai L, Zhang X, Ren B, Shi W, et al. Inhibition of transforming growth factor \u03b2-activated kinase 1 prevents inflammation-related cartilage degradation in osteoarthritis. Sci Rep. 2016;6(1):34497. https:\/\/doi.org\/10.1038\/srep34497.","journal-title":"Sci Rep"},{"issue":"5","key":"2530_CR4","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00296-008-0809-z","volume":"29","author":"YJ Xiang","year":"2009","unstructured":"Xiang YJ, Dai SM. Prevalence of rheumatic diseases and disability in China. Rheumatol Int. 2009;29(5):481\u201390. https:\/\/doi.org\/10.1007\/s00296-008-0809-z.","journal-title":"Rheumatol Int"},{"issue":"7","key":"2530_CR5","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1136\/annrheumdis-2013-204763","volume":"73","author":"M Cross","year":"2014","unstructured":"Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(7):1323\u201330. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204763.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2530_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","volume":"22","author":"TE McAlindon","year":"2014","unstructured":"McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22(3):363\u201388. https:\/\/doi.org\/10.1016\/j.joca.2014.01.003.","journal-title":"Osteoarthritis Cartilage"},{"key":"2530_CR7","first-page":"571","volume":"21","author":"DS Jevsevar","year":"2013","unstructured":"Jevsevar DS. Treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. J Am Acad Orthop Surg. 2013;21:571\u20136.","journal-title":"J Am Acad Orthop Surg"},{"issue":"10077","key":"2530_CR8","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/S0140-6736(17)30059-4","volume":"389","author":"LE Bayliss","year":"2017","unstructured":"Bayliss LE, Culliford D, Monk AP, Glyn-Jones S, Prieto-Alhambra D, Judge A, et al. The effect of patient age at intervention on risk of implant revision after total replacement of the hip or knee: a population-based cohort study. Lancet. 2017;389(10077):1424\u201330. https:\/\/doi.org\/10.1016\/S0140-6736(17)30059-4.","journal-title":"Lancet"},{"issue":"5","key":"2530_CR9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1586\/1744666X.2015.1027151","volume":"11","author":"K Tanaka","year":"2015","unstructured":"Tanaka K, Yamaguchi T, Hara M. Iguratimod for the treatment of rheumatoid arthritis in Japan. Expert Rev Clin Immunol. 2015;11(5):565\u201373. https:\/\/doi.org\/10.1586\/1744666X.2015.1027151.","journal-title":"Expert Rev Clin Immunol"},{"key":"2530_CR10","doi-asserted-by":"publisher","first-page":"109455","DOI":"10.1016\/j.biopha.2019.109455","volume":"119","author":"C Hou","year":"2019","unstructured":"Hou C, Zhu X, Shi C, Peng Y, Huang D, Li Q, et al. Iguratimod (T-614) attenuates severe acute pancreatitis by inhibiting the NLRP3 inflammasome and NF-\u03baB pathway. Biomed Pharmacother. 2019;119:109455. https:\/\/doi.org\/10.1016\/j.biopha.2019.109455.","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"2530_CR11","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/00029330-200804010-00008","volume":"121","author":"LJ L\u00fc","year":"2008","unstructured":"L\u00fc LJ, Teng JL, Bao CD, Han XH, Sun LY, Xu JH, et al. Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial. Chin Med J (Engl). 2008;121(7):615\u20139. https:\/\/doi.org\/10.1097\/00029330-200804010-00008.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"2530_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.intimp.2012.03.003","volume":"13","author":"F Du","year":"2012","unstructured":"Du F, L\u00fc LJ, Teng JL, Shen N, Ye P, Bao CD. T-614 alters the production of matrix metalloproteinases (MMP-1 andMMP-3) and inhibits the migratory expansion of rheumatoid synovial fibroblasts, in vitro. Int Immunopharmacol. 2012;13(1):54\u201360. https:\/\/doi.org\/10.1016\/j.intimp.2012.03.003.","journal-title":"Int Immunopharmacol"},{"key":"2530_CR13","doi-asserted-by":"publisher","unstructured":"Bian J, Dannappel M, Wan C, Firestein R. Transcriptional regulation of Wnt\/\u03b2-catenin pathway in colorectal cancer. Cells. 2020;9(9). https:\/\/doi.org\/10.3390\/cells9092125.","DOI":"10.3390\/cells9092125"},{"issue":"6","key":"2530_CR14","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse R, Clevers H. Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169(6):985\u201399. https:\/\/doi.org\/10.1016\/j.cell.2017.05.016.","journal-title":"Cell"},{"issue":"3","key":"2530_CR15","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/cphy.c140060","volume":"5","author":"KC Hermans","year":"2015","unstructured":"Hermans KC, Blankesteijn WM. Wnt signaling in cardiac disease. Compr Physiol. 2015;5(3):1183\u2013209. https:\/\/doi.org\/10.1002\/cphy.c140060.","journal-title":"Compr Physiol"},{"issue":"2","key":"2530_CR16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.7150\/thno.29055","volume":"9","author":"L Ren","year":"2019","unstructured":"Ren L, Chen H, Song J, Chen X, Lin C, Zhang X, et al. MiR-454-3p-mediated Wnt\/\u03b2-catenin signaling antagonists suppression promotes breast cancer metastasis. Theranostics. 2019;9(2):449\u201365. https:\/\/doi.org\/10.7150\/thno.29055.","journal-title":"Theranostics"},{"issue":"6","key":"2530_CR17","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.3892\/etm.2020.8624","volume":"19","author":"G Wu","year":"2020","unstructured":"Wu G, Huang Y, Chen W, Chen J, Lu X, Liu X, et al. Tougu Xiaotong capsule exerts a therapeutic effect by improving knee meniscus in the early osteoarthritis rat model. Exp Ther Med. 2020;19(6):3641\u20139. https:\/\/doi.org\/10.3892\/etm.2020.8624.","journal-title":"Exp Ther Med"},{"key":"2530_CR18","volume-title":"Knee osteoarthritis: a review of pathogenesis and state-of-the-art non-operative therapeutic considerations","author":"D Primorac","year":"2020","unstructured":"Primorac D, Molnar V. Knee osteoarthritis: a review of pathogenesis and state-of-the-art non-operative therapeutic considerations, vol. 11; 2020."},{"key":"2530_CR19","unstructured":"Wang M, Ju S, Liu P, He B, Chen HA. Comparative study on the rat models of knee osteoarthritis induced by papain, sodium iodoacetate and type II collagenase. Sichuan Med J. 2020;42(2):126\u201331."},{"issue":"6","key":"2530_CR20","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1159\/000430208","volume":"36","author":"G Du","year":"2015","unstructured":"Du G, Song Y, Wei L, Li L, Wang X, Xu Q, et al. Osthole inhibits proliferation and induces catabolism in rat chondrocytes and cartilage tissue. Cell Physiol Biochem. 2015;36(6):2480\u201393. https:\/\/doi.org\/10.1159\/000430208.","journal-title":"Cell Physiol Biochem"},{"key":"2530_CR21","doi-asserted-by":"crossref","unstructured":"Akeson G, Malemud CJ. A role for soluble IL-6 receptor in osteoarthritis. J Funct Morphol Kinesiol. 2017;2:27.","DOI":"10.3390\/jfmk2030027"},{"key":"2530_CR22","doi-asserted-by":"publisher","first-page":"106745","DOI":"10.1016\/j.intimp.2020.106745","volume":"86","author":"X Li","year":"2020","unstructured":"Li X, Mei W, Huang Z, Zhang L, Zhang L, Xu B, et al. Casticin suppresses monoiodoacetic acid-induced knee osteoarthritis through inhibiting HIF-1\u03b1\/NLRP3 inflammasome signaling. Int Immunopharmacol. 2020;86:106745. https:\/\/doi.org\/10.1016\/j.intimp.2020.106745.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"2530_CR23","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00296-012-2548-4","volume":"33","author":"M Xu","year":"2013","unstructured":"Xu M, Zhang L, Zhao L, Gao S, Han R, Su D, et al. Phosphorylation of osteopontin in osteoarthritis degenerative cartilage and its effect on matrix metalloprotease 13. Rheumatol Int. 2013;33(5):1313\u20139. https:\/\/doi.org\/10.1007\/s00296-012-2548-4.","journal-title":"Rheumatol Int"},{"issue":"49","key":"2530_CR24","doi-asserted-by":"publisher","first-page":"17192","DOI":"10.1073\/pnas.0407788101","volume":"101","author":"M Inada","year":"2004","unstructured":"Inada M, Wang Y, Byrne MH, Rahman MU, Miyaura C, L\u00f3pez-Ot\u00edn C, et al. Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc Natl Acad Sci U S A. 2004;101(49):17192\u20137. https:\/\/doi.org\/10.1073\/pnas.0407788101.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2530_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cytogfr.2018.10.002","volume":"44","author":"T Wang","year":"2018","unstructured":"Wang T, He C. Pro-inflammatory cytokines: the link between obesity and osteoarthritis. Cytokine Growth Factor Rev. 2018;44:38\u201350. https:\/\/doi.org\/10.1016\/j.cytogfr.2018.10.002.","journal-title":"Cytokine Growth Factor Rev"},{"key":"2530_CR26","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.12659\/msm.893771","volume":"21","author":"Y Liu","year":"2015","unstructured":"Liu Y, Peng H, Meng Z, Wei M. Correlation of IL-17 level in Synovia and Severity of Knee Osteoarthritis. Med Sci Monit. 2015;21:1732\u20136. https:\/\/doi.org\/10.12659\/msm.893771.","journal-title":"Med Sci Monit"},{"issue":"1","key":"2530_CR27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/s12891-016-1286-2","volume":"17","author":"A Dell'Isola","year":"2016","unstructured":"Dell'Isola A, Allan R, Smith SL, Marreiros SS, Steultjens M. Identification of clinical phenotypes in knee osteoarthritis: a systematic review of the literature. BMC Musculoskelet Disord. 2016;17(1):425. https:\/\/doi.org\/10.1186\/s12891-016-1286-2.","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"2530_CR28","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.3892\/etm.2017.4684","volume":"14","author":"X Yu","year":"2017","unstructured":"Yu X, Zhao L, Yu Z, Yu C, Bi J, Sun B, et al. Sivelestat sodium hydrate improves post-traumatic knee osteoarthritis through nuclear factor-\u03baB in a rat model. Exp Ther Med. 2017;14(2):1531\u20137. https:\/\/doi.org\/10.3892\/etm.2017.4684.","journal-title":"Exp Ther Med"},{"key":"2530_CR29","doi-asserted-by":"crossref","unstructured":"Liu X, Wang L, Ma C, Wang G, Zhang Y, Sun S. Exosomes derived from platelet-rich plasma present a novel potential in alleviating knee osteoarthritis by promoting proliferation and inhibiting apoptosis of chondrocyte via Wnt\/\u03b2-catenin signaling pathway. J Orthop Surg Res. 2019;14:470.","DOI":"10.1186\/s13018-019-1529-7"},{"issue":"1","key":"2530_CR30","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3892\/mmr.2019.10239","volume":"20","author":"Y He","year":"2019","unstructured":"He Y, Moqbel SAA, Xu L, Ran J, Ma C, Xu K, et al. Costunolide inhibits matrix metalloproteinases expression and osteoarthritis via the NF-\u03baB and Wnt\/\u03b2-catenin signaling pathways. Mol Med Rep. 2019;20(1):312\u201322. https:\/\/doi.org\/10.3892\/mmr.2019.10239.","journal-title":"Mol Med Rep"},{"issue":"1","key":"2530_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.yexcr.2017.10.012","volume":"361","author":"X Wang","year":"2017","unstructured":"Wang X, Ning Y, Zhang P, Yang L, Wang Y, Guo X. Chondrocytes damage induced by T-2 toxin via Wnt\/\u03b2-catenin signaling pathway is involved in the pathogenesis of an endemic osteochondropathy, Kashin-Beck disease. Exp Cell Res. 2017;361(1):141\u20138. https:\/\/doi.org\/10.1016\/j.yexcr.2017.10.012.","journal-title":"Exp Cell Res"},{"issue":"9","key":"2530_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11926-017-0679-z","volume":"19","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Wang T, Hamilton JL. Chen D Wnt\/\u03b2-catenin signaling in osteoarthritis and in other forms of arthritis. Curr Rheumatol Rep. 2017;19(9):53. https:\/\/doi.org\/10.1007\/s11926-017-0679-z.","journal-title":"Curr Rheumatol Rep"},{"key":"2530_CR33","first-page":"769","volume":"45","author":"Z Shu","year":"2020","unstructured":"Shu Z, Miao X, Tang T, Zhan P, Zeng L, Jiang Y. The GSK-3\u03b2\/\u03b2-catenin signaling pathway is involved in HMGB1-induced chondrocyte apoptosis and cartilage matrix degradation. Int J Mol Med. 2020;45:769\u201378.","journal-title":"Int J Mol Med"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-021-02530-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-021-02530-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-021-02530-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T14:07:28Z","timestamp":1624370848000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-021-02530-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2530"],"URL":"https:\/\/doi.org\/10.1186\/s13018-021-02530-2","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,22]]},"assertion":[{"value":"17 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Animal Ethics Committee of Xinjiang Medical University. All experiments were carried out in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"403"}}